This company is worth at least aroudn 1.50 to 1.75 right now, regardless if this does or doesn't get approved, so needless to say it's very undervalued and should, at some point, get back to trading around those levels or higher. I would recomend getting in if this gets approved right away, as you should be able to ride it up for good gains regardless if you get in a bit behind the rest here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.